Cargando…

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease

Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell transplantation and a major cause of morbidity and mortality in affected patients. Especially skin, eyes and oral mucosa are affected. This can lead to pain and functional impairment. Extracorporeal photopheres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franklin, Cindy, Cesko, Elvir, Hillen, Uwe, Schilling, Bastian, Brandau, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524718/ https://www.ncbi.nlm.nih.gov/pubmed/26241482 http://dx.doi.org/10.1371/journal.pone.0134518

Ejemplares similares

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
por: Kozlov, Andrey, et al.
Publicado: (2021)

1088. Extracorporeal Photopheresis and Infectious Complications in Patients with Chronic Graft Versus Host Disease
por: Ashraf, Nida, et al.
Publicado: (2020)

Extracorporeal photopheresis in chronic graft-versus-host disease: clinical description and economic study
por: Vargas, Dora Fraga, et al.
Publicado: (2023)

Guidelines on the use of extracorporeal photopheresis
por: Knobler, R, et al.
Publicado: (2014)

Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
por: Malik, Mohsin Ilyas, et al.
Publicado: (2014)

Novel Application of Extracorporeal Photopheresis as Treatment of Graft-versus-Host Disease Following Liver Transplantation
por: Brown, Timothy J., et al.
Publicado: (2017)

Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience
por: Calore, Elisabetta, et al.
Publicado: (2015)

Extracorporeal Photopheresis—An Overview
por: Cho, Ara, et al.
Publicado: (2018)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
por: Sarmiento Maldonado, Mauricio, et al.
Publicado: (2017)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
por: Rafei, Hind, et al.
Publicado: (2017)

Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
por: Afram, Gabriel, et al.
Publicado: (2019)

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
por: Alfred, Arun, et al.
Publicado: (2017)

Cognitive Factors Mediate Placebo Responses in Patients with House Dust Mite Allergy
por: Vits, Sabine, et al.
Publicado: (2013)

Extracorporeal photopheresis: Review of technical aspects
por: Arora, Satyam, et al.
Publicado: (2017)

Modified Extracorporeal Photopheresis with Cells from a Healthy Donor for Acute Graft-versus-Host Disease in a Mouse Model
por: Budde, Holger, et al.
Publicado: (2014)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
por: Castillo-Aleman, Yandy Marx
Publicado: (2022)

Effects of Ramadan Fasting on Extracorporeal Photopheresis Outcomes
por: Castillo-Aleman, Yandy M, et al.
Publicado: (2023)

P1578: SERUM EXTRACELLULAR VESICLE MIRNA PROFILING TO DETERMINE EXTRACORPOREAL PHOTOPHERESIS TREATMENT RESPONSE IN GRAFT VERSUS HOST DISEASE PATIENTS
por: Schell, Kimberly, et al.
Publicado: (2023)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
por: Mankarious, Matthew, et al.
Publicado: (2020)

Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker
por: Lopes, Sérgio Machado, et al.
Publicado: (2020)

Effects of Extracorporeal Photopheresis on Quality of Life and the Course of Diseases in Patients With Mycosis Fungoides and Graft-Versus-Host Disease: A Single-Center Analysis
por: Vogiatzis, Romanos, et al.
Publicado: (2023)

Extracorporeal Photopheresis Improves Graft Survival in a Full-Mismatch Rat Model of Kidney Transplantation
por: Piñeiro, Gaston J., et al.
Publicado: (2023)

Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study
por: Christensen, Eidi, et al.
Publicado: (2021)

Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease
por: Radwanski, Katherine, et al.
Publicado: (2020)

Effect of extracorporeal photopheresis on selected immunologic parameters in psoriasis vulgaris.
por: Vonderheid, E. C., et al.
Publicado: (1989)

Extracorporeal photopheresis during the COVID-19 pandemic: experience in Argentina
por: Baquero Rey, Jenny Andrea, et al.
Publicado: (2021)

GVHD treatment with extracorporeal photopheresis in Brazil: a national survey
por: Fatobene, Giancarlo, et al.
Publicado: (2022)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
por: Dieterlen, Maja-Theresa, et al.
Publicado: (2021)

Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain
por: Boluda, Blanca, et al.
Publicado: (2021)

Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome—results from a large single-center study
por: Berger, Massimo, et al.
Publicado: (2015)

Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Spałek, Adrianna, et al.
Publicado: (2022)

P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
por: Gavriilaki, Eleni, et al.
Publicado: (2023)

Extracorporeal Photopheresis: Tolerogenic or Immunogenic Cell Death? Beyond Current Dogma
por: Hannani, Dalil
Publicado: (2015)

Successful treatment of Sezary syndrome with extracorporeal photopheresis – The first attempt in India
por: Tiwari, Aseem K., et al.
Publicado: (2019)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
por: Flinn, Aisling M., et al.
Publicado: (2020)

Shaping of CD56(bri) Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis
por: Ni, Ming, et al.
Publicado: (2019)

Extracoporeal photopheresis treatment of acute graft-versus-host disease following allogeneic haematopoietic stem cell transplantation
por: Flinn, Aisling M., et al.
Publicado: (2016)

Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study
por: Sassone, Adriana, et al.
Publicado: (2023)

Human Apoptotic Cells, Generated by Extracorporeal Photopheresis, Modulate Allogeneic Immune Response
por: Pilon, Caroline, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ulub8nkjgekrr281u1vfma69o0